Real-World Use of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Single-Centre Retrospective Descriptive Analysis. [PDF]
Clin Cosmet Investig DermatolAlmutlaq H.
europepmc +1 more source
Dual-Targeted Therapy With Upadacitinib and Ustekinumab in Pediatric Refractory Perianal Crohn's Disease. [PDF]
ACG Case Rep JSathe N +4 more
europepmc +1 more source
Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis. [PDF]
An Bras DermatolDemir Y +4 more
europepmc +1 more source
ObjectiveTo assess the development of extramusculoskeletal manifestations (EMMs) among patients with psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA) treated with upadacitinib 15 mg.MethodsData (cutoff: August 15, 2022) from five clinical ...
Biljan, Ana +11 more
core
Diagnosis of mycosis fungoides following upadacitinib treatment. [PDF]
JAAD Case RepJones T, Jacoby TV, Wu PA.
europepmc +1 more source
Upadacitinib Induces Rapid Remission in Refractory Eosinophilic Pustular Folliculitis with Facial Involvement: A Case Report. [PDF]
Acta Derm VenereolWang Y, Su J, Jin H.
europepmc +1 more source
Short-term disease control with alternate-day maintenance upadacitinib in refractory Hailey-Hailey disease: a case report. [PDF]
Front ImmunolLuo D, Yang F, Zhao Z, Li H, Guan L.
europepmc +1 more source
Case Report: Near-complete resolution of nail psoriasis with upadacitinib in a pediatric patient. [PDF]
Front ImmunolHuang Y, Wen S.
europepmc +1 more source
Effect of JAK Inhibitors on Fatigue and Sleep Quality in Patients with Rheumatoid Arthritis: A Narrative Review. [PDF]
J Clin MedKowalska A +5 more
europepmc +1 more source
Upadacitinib in Rheumatoid Arthritis After Prior TNF Inhibitor Failure: A 12-Month Multicenter Real-World Study. [PDF]
J Clin Pract ResBakay U, Kaban N.
europepmc +1 more source